An additional advantage in using HER2 as a diagnostic tool is the fact that its positive staining in CIS cases involves the deeper urothelial layers; therefore, HER2 may be applied even to tissue samples whose urothelial lining is not intact, which is a quite common occurrence in TUR specimens [26]. This evidence concerns the gene ERBB2 and in situ carcinoma.